Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2016 Jun 9;6:27730. doi: 10.1038/srep27730

Genetic diversity, seasonality and transmission network of human metapneumovirus: identification of a unique sub-lineage of the fusion and attachment genes

Wei Zhen Chow 1, Yoke Fun Chan 2, Xiang Yong Oong 1, Liang Jie Ng 3, Siti Sarah Nor’E 4, Kim Tien Ng 1, Kok Gan Chan 5, Nik Sherina Hanafi 6, Yong Kek Pang 1, Adeeba Kamarulzaman 1, Kok Keng Tee 2,a
PMCID: PMC4899729  PMID: 27279080

Abstract

Human metapneumovirus (HMPV) is an important viral respiratory pathogen worldwide. Current knowledge regarding the genetic diversity, seasonality and transmission dynamics of HMPV among adults and children living in tropical climate remains limited. HMPV prevailed at 2.2% (n = 86/3,935) among individuals presented with acute respiratory tract infections in Kuala Lumpur, Malaysia between 2012 and 2014. Seasonal peaks were observed during the northeast monsoon season (November–April) and correlated with higher relative humidity and number of rainy days (P < 0.05). Phylogenetic analysis of the fusion and attachment genes identified the co-circulation of three known HMPV sub-lineages, A2b and B1 (30.2% each, 26/86) and B2 (20.9%, 18/86), with genotype shift from sub-lineage B1 to A2b observed in 2013. Interestingly, a previously unrecognized sub-lineage of A2 was identified in 18.6% (16/86) of the population. Using a custom script for network construction based on the TN93 pairwise genetic distance, we identified up to nine HMPV transmission clusters circulating as multiple sub-epidemics. Although no apparent major outbreak was observed, the increased frequency of transmission clusters (dyads) during seasonal peaks suggests the potential roles of transmission clusters in driving the spread of HMPV. Our findings provide essential information for therapeutic research, prevention strategies, and disease outbreak monitoring of HMPV.


Human metapneumovirus (HMPV) is a single-stranded RNA virus classified in the Metapneumovirus genus within the Pneumovirinae sub-family of Paramyxoviridae. Since the first description of HMPV among children in the Netherlands1, the virus has emerged as one of the main causative agents of acute respiratory tract infections (RTIs) across all ages worldwide, in addition to the human respiratory syncytial virus (HRSV)2,3,4,5,6,7,8. The clinical presentation of acute and severe RTIs due to HMPV are strikingly similar to that of HRSV which are mainly characterised by mild respiratory illnesses to severe cough, bronchiolitis, pneumonia and often accompanied by high fever, myalgia and vomiting1. In the United States for example, the annual disease burden due to HMPV in hospitalized children below 5 years of age has been estimated at 1 per 1000 children, similar to that of the influenza virus9.

HMPV is classified into two main genetic lineages denoted as genotypes A and B based on the phylogenetic analysis of the fusion (F) and attachment (G) genes. Each genotype is further classified into at least two sub-lineages – A1, A2, B1 and B210. It was later reported that two additional genetic sub-lineages were described within the A2 sub-lineage, named A2a and A2b based on the phylogenetic analysis of the nucleocapsid (N) and F gene sequences in a population of paediatric patients11. Different genetic sub-lineages of HMPV also co-circulate in a temporal fashion and a shift in the predominant circulating strain is not uncommon12,13,14.

Acute respiratory infections caused by viruses such as HRSV, influenza A virus and human parainfluenza virus, amongst others are seasonally-distributed15. In temperate countries, a higher prevalence of HMPV has been reported during the months of winter and spring, with a lower seasonality than HRSV2,13,14,15,16. Climate also plays an important role in determining the seasonality of HMPV in tropical countries. Previous studies have described a direct correlation between the number of rainy days and the increase in the number of HMPV infections6,8. In addition to the number of rainy days, the effects of other important factors in a tropical climate such as the relative humidity, temperature and amount of rainfall on the prevalence of HMPV need to be investigated in order to provide a better understanding of its seasonality.

Molecular epidemiological surveillance can be used to infer the dynamics of disease transmission based on the genetic relatedness of viral sequences derived from the population, as shown for human immunodeficiency virus (HIV)17,18,19, influenza virus20,21, echovirus22 and ebola virus23, amongst others. Although HMPV is one of the main causative agents of RTIs worldwide, little is known about the temporal dynamics of HMPV transmission in the population. Transmission networks inferred from the analysis of viral sequences elucidate the degree of the spread of an infection in a subset of the population that allows the identification of the population at high risk of transmitting the virus amongst each other, thus enabling the implementation of effective and targeted public health preventive measures to reduce the prevalence of new infections in the population at large17,18,24.

To date, studies on the epidemiological distribution and genetic diversity of HMPV have been reported mainly among the hospitalised and outpatient children worldwide4,7,12,25,26. Despite the significant burden of acute RTIs due to HMPV9, information regarding the seasonal distribution, circulating genotypes and the dynamics of disease transmission of HMPV in the general population of all ages in tropical countries are currently limited6,8,27. In this study, we aimed to investigate the genetic diversity, seasonality and transmission network of HMPV infections among outpatient adults and children in Kuala Lumpur, Malaysia during a two-year period.

Results

Characteristics of the study population and seasonality of HMPV

Between February 2012 and May 2014, a total of 3,935 nasopharyngeal samples were collected (comprising 3,706 adults and 229 children), among which 86 (2.2%) samples were tested positive for HMPV. Among the infected individuals, seven (8.1%) were co-infected with other respiratory virus, whereby six individuals were dually co-infected with either rhinovirus (n = 3), adenovirus (n = 1), influenza B (n = 1) or coronavirus (n = 1) while one individual was triply co-infected with rhinovirus and influenza A. Co-infection with HRSV was not observed. The study population was comprised predominantly of females (61.6%, 53/86). Among 86 individuals infected with HMPV, 76.7% (n = 66) were adults (median age: 34.0 years, interquartile range, IQR, 26.0–54.0 years), 18.6% (n = 16) were elderly, defined as ≥65 years old2 (median age: 72.0 years, IQR, 69.8–75.0 years) and the remaining 4.7% (n = 4) were children (median age: 14.5 years, IQR, 12.8–16.3 years). The population was ethnically diverse, comprising of Malays (46.5%, 40/86), Indians (26.7%, 23/86), Chinese (23.3%, 20/86) and other ethnic groups (3.5%, 3/86). Overall, the patients reported a median total of 4.0 days (IQR, 3.0–7.0 days) since the onset of disease symptoms. Majority of the patients reported symptoms of cough (98.8%), followed by hoarseness of voice (89.5%), nasal discharge (72.1%), sneezing (70.9%), headache (69.8%), sore throat (69.8%), nasal congestion (67.4%) and muscle ache (65.1%). During the 28-months period, a higher prevalence of HMPV infections were reported in March 2012, April and November 2013 (Fig. 1).

Figure 1. The distribution of human metapneumovirus (HMPV) among 86 adults and children presented with acute upper respiratory tract infections (URTI) between February 2012 and May 2014 in Kuala Lumpur, Malaysia.

Figure 1

The monthly distribution of HMPV and its prevalence (number of HMPV-positive samples/total number of samples collected within the month × 100%) among a total of 3,935 nasopharyngeal samples.

Next, we assessed the effects of various meteorological factors in the context of a tropical climate on the prevalence of HMPV throughout the study period. The prevalence of HMPV significantly correlated with higher relative humidity (r = 0.449, P = 0.019) and number of rainy days (r = 0.440, P = 0.022). On the other hand, an inverse correlation between the prevalence of HMPV with the ground temperature (r = −0.281, P = 0.155) and particulate matter measuring 10 μm or less in diameter (PM10) (r = −0.163, P = 0.417) was observed, although the observation was statistically non-significant. The total amount of rainfall (r = 0.235, P = 0.258) was also associated with the prevalence of HMPV, although the observation was statistically non-significant.

Phylogenetic analysis and genetic diversity of the F and G genes

Among the 86 samples positive for HMPV infection, the partial F and G genes were successfully amplified in 98.8% (85/86) and 95.3% (82/86) of the total samples, respectively. Phylogenetic analysis of the newly-sequenced and reference partial F and G gene sequences showed the clustering of the sequences into two main genotypes - A and B, and at least five known sub-lineages – A1, A2a, A2b, B1 and B2, in agreement with previous studies (Fig. 2A,B)10,11,12. Within genotype A, a total of 30.2% (26/86) of the newly-generated sequences clustered within the A2b sub-lineage. Interestingly, 18.6% (16/86) of the sequences clustered with a reference strain, HMPV CN/gz01/08/A2 (accession number: GQ153651) within a previously unrecognized sub-lineage of A2, supported by a strong bootstrap value of 98–99% in the phylogenies of both F and G genes. The unique clade was provisionally assigned as a novel sub-lineage of A2. In addition to Malaysia, previously published sequences from other countries (China, Vietnam, and Cambodia) were also grouped within this clade. Both A1 and A2a sub-lineages were not detected in our study population. Similarly, within genotype B, a total of 30.2% (26/86) of the sequences clustered within the B1 sub-lineage and 20.9% (18/86) of the sequences clustered within the B2 sub-lineage. In 2012, B1 sub-lineage circulated predominantly at 39.5% (15/38) of the population and a shift in the predominant genotype towards A2b (29.4%, 10/34) was observed in 2013 (Fig. 3). Between January and May 2014, both A2b and B2 sub-lineages co-circulated at equal prevalence at 35.7% (5/14). In addition to samples collected from four children in our current study population, phylogenetic analysis of the F and G genes sequenced from 21 paediatric patients recruited between April 2010 and December 2012 (median age: 1.84 years, IQR, 1.11–3.40) revealed that 52.0% (13/25) of the sequences clustered within the novel sub-lineage of A2, followed by A2b and B1 at 20.0% (5/25) each, and A2a and B2 at 4.0% (1/25) each (Fig. 2A,B). No sequences were detected in the A1 sub-lineage.

Figure 2. Phylogenetic analyses of the human metapneumovirus (HMPV) among the adults and children between February 2012 and May 2014 in Kuala Lumpur.

Figure 2

The newly-sequenced (A) fusion (F) and (B) attachment (G) gene sequences from adults and children plus previously reported paediatric sequences from Malaysia7 were included in the neighbour joining tree analysis implemented in MEGA. Reference strains (blue triangles) of HMPV sub-lineages included AF371337 HMPV NL/1/00/A1, AY297749 HMPV CA/83/97/A2a, AY530095 HMPV JP/240/03/A2b, GQ153651 HMPV CN/gz01/08/A2, AY525843 HMPV NL/1/99/B1 and GQ153651 HMPV CA/75/98/B21,12. All sequences were labelled according to the approved nomenclature of HMPV by the International Committee on Taxonomy of Viruses (ICTV)53. Country of origin for the reference and other database sequences was indicated in the tree by their respective country codes (AU, Australia; AR, Argentina; CA, Canada; KH, Cambodia, CN, China; IN, India; JP, Japan; NL, Netherlands; PE, Peru; SG, Singapore; TH, Thailand; TW, Taiwan; US, United States of America; UY, Uruguay and VN, Vietnam). The genotype classification was concordant between both F and G genes. Bootstrap values of greater than 70% were indicated on the branch nodes. The scale bars represent 1% and 5% genetic distances for F and G genes, respectively (0.01 and 0.05 substitutions per site).

Figure 3. Annual prevalence of human metapneumovirus (HMPV) genotypes and sub-lineages co-circulating among 86 adults and children between 2012 and 2014 in Kuala Lumpur, Malaysia.

Figure 3

The prevalence is denoted in % (n, frequency of each sub-lineage within that year).

Based on the estimation of intra-genotype mean genetic distances of nucleotide and amino acid sequences of HMPV, F gene has higher sequence identities overall compared to G gene at both nucleotide (nt) and amino acid (aa) levels (F gene, nt: 88.7% and aa: 75.9% vs G gene: nt: 54.3% and aa: 27.6%, respectively) (Table 1). Sequences within the novel sub-lineage of A2 were highly identical at both nucleotide and amino acid levels in both F and G genes (F gene, nt: 99.1% and aa: 97.5% and G gene: nt: 95.7% and aa: 95.5%). Next, we estimated the inter-genotype mean genetic distances of the HMPV genotypes and sub-lineages (Table 2). Sub-lineage distances between genotypes A and B were high in both F and G genes, estimated around 17.7–19.3% and 77.8–88.3%, respectively. Sub-lineage distances within genotype were estimated around 5.9–7.5% and 22.6–26.9% in the F and G genes, respectively. Within A2, genetic distances between sub-lineages A2a and A2b were 3.8% in the F gene and 13.0% in the G gene. Notably, the genetic distances between these sub-lineages and the novel sub-lineage of A2 were similar or higher, estimated around 3.6–4.4% and 11.9–12.9% in both the F and G genes, respectively. Specific amino acid substitutions were also present within the novel sub-lineage of A2 in the G protein, but not in the F gene. In comparison with A2a and A2b sub-lineages, eleven specific amino acid substitutions in the novel sub-lineage of A2 were identified at positions 40, 59, 93, 106, 148, 164, 188, 197, 199, 216 and 227 (Table 3). Taken together, based on the phylogenetic tree topology, genetic distances and specific amino acid substitution analyses in both the F and G genes, the newly identified sub-lineage was distinct from the previously described A2a and A2b sub-lineages.

Table 1. Estimated mean sequence identities of the human metapneumovirus (HMPV) genotype and sub-lineages in the fusion (F) and attachment (G) genes at the nucleotide and amino acid levels.

Gene/protein Genotype/sub-lineage Mean identity (%)
Nucleotide Amino acid
F Overall 88.7 75.9
  Within A 96.7 90.4
  Within A1 98.8 96.7
  Within A2a 99.0 97.7
  Within A2b 98.6 95.8
  Within novel A2 sub-lineage 99.1 97.5
  Within B 95.8 91.3
  Within B1 98.4 95.8
  Within B2 98.5 96.5
G Overall 54.3 27.6
  Within A 88.6 81.9
  Within A1 93.9 90.5
  Within A2a 96.6 94.8
  Within A2b 95.0 93.2
  Within novel A2 sub-lineage 95.2 91.9
  Within B 84.3 74.2
  Within B1 96.5 94.7
  Within B2 95.6 91.1

Table 2. Estimated mean genetic distances between each genotype and sub-lineage of human metapneumovirus (HMPV) in the fusion (F) and attachment (G) genes (in %).

Gene Genotype/sub-lineage A1 A2a A2b Novel A2 sub-lineage B1 B2
F A1   0.9 1.1 1.2 1.8 1.9
  A2a 5.9   0.7 0.8 2.0 1.9
  A2b 7.5 3.8   0.7 2.1 2.0
  Novel A2 sub-lineage 7.9 4.4 3.6   2.0 2.0
  B1 17.7 18.4 19.0 18.7   1.1
  B2 18.2 18.5 19.3 19.3 7.0  
G A1   1.7 1.8 2.0 5.4 4.7
  A2a 22.6   1.1 1.2 4.9 5.0
  A2b 25.0 13.0   1.0 5.4 5.6
  Novel A2 sub-lineage 27.4 12.9 11.9   5.5 6.0
  B1 87.7 78.5 85.7 85.8   2.1
  B2 81.8 77.8 86.6 88.3 26.9  

Standard error estimates of the mean genetic distances are shown in the upper diagonal panel.

Table 3. Lineage-specific amino acid substitutions within the human metapneumovirus (HMPV) sub-lineages of A2 in the attachment (G) protein open reading frame between position 14 and 228a.

A2 sub-lineage Amino acid position in the G gene
40 59 93 106 148 164 188 197 199 216 227
A2a T T H P V P T T T T P
A2b T T H P V P T T V T P
Novel sub-lineage of A2 A A L S A S A I A A T

aThe position of amino acid was determined according to HMPV reference genotype A2, AY304360 HMPV NL/17/00/A2a.

HMPV transmission network

In order to elucidate the dynamics of HMPV transmission among the adults and children population in the present study, we constructed transmission networks based on the pairwise distances using the TN93 model estimated from the newly-sequenced F and G genes. The lower 0.025 percentile of the inter-person genetic distances from database sequences, which represented the patristic distance cutoff for transmission cluster interpretation, were estimated at 0.2% and 1.2% for the F and G genes, respectively (Supplementary Table 1). In the F gene data set, 19 sequences (22.4%, 19/85) formed a total of nine clusters (comprising of eight dyads and one network) while in the G gene, 11 sequences (13.4%, 11/82) formed a total of five clusters (comprising of four dyads and one network), ranging between two and three individuals in size (Fig. 4A). Of these clusters, only two dyads and one network were concordant in both genes. Overall, more transmission clusters were observed in the A2b sub-lineage than other sub-lineages in both the F (57.9%, 11/19) and G (63.6%, 7/11) genes. A known transmission pair of two epidemiologically-linked adult and child infected with the novel A2 sub-lineage was also observed in the F (but not in the G) gene. HMPV has been reported to be highly infectious within the first 4–6 days of infection28, after which its ability to cause infection in another individual declines. Hence we proceed to estimate the difference between estimated date of infection (denoted as ΔEDI) between existing members of clusters observed in the F and G genes to evaluate the reliability of the genetic-based approach in inferring transmission network. We found that a majority of the clusters inferred in the F (8/9 clusters) and G genes (4/5 clusters) had ΔEDIs of ≤7 days which provided substantial validation of the method used in this study (Fig. 4A). Of note, the frequency of transmission clusters identified during the study period coincided with an increase in the detection of the respective HMPV sub-lineages in the population, as observed in the A2b (between September 2012 and April 2013) and B1 (between March and April 2012) sub-lineages (Fig. 4A,B).

Figure 4. Human metapneumovirus (HMPV) transmission network among the adults and children in Kuala Lumpur between February 2012 and May 2014.

Figure 4

The transmission network was inferred from the newly-sequenced F (n = 85) and G (n = 82) genes based on the Tamura-Nei 93 (TN93) pairwise distance estimates51 performed using a custom script in Python (release 3.2.6) with 1,000 bootstrap replicates. (A) The monthly distribution of transmission clusters inferred for F and G genes at the genetic distance cutoffs of 0.2% and 1.2%, respectively. The three common transmission clusters identified in both genes were highlighted in circles (dotted lines). Probable direction of disease transmission within a cluster was estimated by placing a directed edge from the putative “donor” node to the “recipient” node(s), where the estimated date of infection, EDIdonor is older than the EDIrecipient18. (B) The monthly frequency (in absolute numbers of samples/individuals) of HMPV sub-lineages co-circulating in the study population. HMPV sub-lineages A2b, B1, B2, and the novel sub-lineage of A2 were indicated by their respective colours.

Discussion

To date, most studies were focused on describing the molecular epidemiology of HMPV in hospitalised children4,7,12,25,26 and consequently, knowledge regarding the prevalence and genotypic distribution among the general population of all ages are limited6,29. In addition, the seasonality and dynamics of disease transmission in countries with a tropical climate have not been analysed in detail. In the present study, we reported the recent molecular epidemiology of HMPV in an outpatient population of adults and children presented with symptoms of acute URTI in Kuala Lumpur during a two-year period. From 3,935 nasopharyngeal swabs collected between 2012 and 2014, the average prevalence of HMPV in the population was fairly low at around 2%, similar to previous studies conducted across all ages6. Conversely, HMPV was more prevalent among children in the hospitalised or community setting, with a reported prevalence of over 5% particularly among the young and immunocompromised children1,3,4,25,30. Although the overall prevalence of HMPV infection was low in our study population, a relatively higher monthly prevalence of up to 4–5% was observed during the November–April period (Fig. 1), coincided with the northeast monsoon season which typically occurs in the region between October and March. We also showed that the prevalence of HMPV was significantly correlated with high relative humidity and the number of rainy days.

Throughout the study period, both HMPV genotypes A and B, including three known sub-lineages – A2b, B1 and B2 co-circulated all year round. Meanwhile, sub-lineages A1 and A2a were not detected in our study population. Similarly, sub-lineage A1 which circulated in China31, was also not detected in the neighbouring regions including Cambodia6, Thailand8 and Singapore4; and worldwide after 2006, in Austria13, Argentina32, Australia33, Canada12, and the United States34,35. On the other hand, sub-lineage A2a circulated widely at a low prevalence in other countries including Thailand8 and Canada36. Both A2b and B1 circulated predominantly in the population, with a combined prevalence of around 60% (Fig. 3). We also observed a shift in the predominant circulating genotype from sub-lineage B1 to A2b in the population between 2012 and 2013, although a longer study period with more samples may be required to provide an accurate representation. Recently, genotype A2 has been associated with a more severe disease in hospitalised children in Jordan and Cambodia6,37. Further studies to assess the impact of HMPV genotypes on disease severity are warranted. In addition to the known sub-lineages, a previously unreported sub-lineage of A2 was identified at a lower prevalence at around 19% in the population. Phylogenetic and pairwise distance analyses of the F and G genes sequence data including all publicly available global reference sequences confirmed the novelty of the sub-lineage which was distinct from other known sub-lineages within A2, such as A2a and A2b (Fig. 2, Table 2). More than half of the F and G sequences previously amplified among Malaysian children between 2010 and December 20127 were grouped within the novel sub-lineage of A2. Furthermore, several reference F and G gene sequences isolated from neighbouring countries including Vietnam, Cambodia and China, sampled between 2006 and 2011 also clustered with the Malaysian sequences within the novel sub-lineage of A2 and further suggesting that the novel sub-lineage of A2 might have been circulating in the region at a lower prevalence earlier (Fig. 2). Further studies however are required to estimate its time of emergence in our study population and whether the proposed novel sub-lineage of A2 is also circulating in other regions besides Southeast and East Asia. Complete genome sequencing followed by rigorous phylogenetic and genetic distance analyses of the novel sub-lineage of A2 are necessary to confirm its assignment as a distinct sub-lineage.

Analysis of epidemiological data is generally useful to estimate the temporal prevalence and seasonality of a viral pathogen. However the inclusion of transmission network information could elucidate the spread and dynamics of a disease attributed to specific genotypes or sub-lineages circulating in the population that further corroborate the observation from epidemiological surveillance of a disease. Using programming language-based approach, we inferred the transmission network of HMPV in the population based on the genetic sequences of the F and G genes. To the best of our knowledge, such analysis represents the first of which the spread and dynamics of HMPV transmission in the general population was mapped. Using the estimated cutoffs for the pairwise genetic distance between HMPV sequences and the EDI between individuals, below which individuals were classified as a transmission cluster, we identified up to nine transmission clusters (in the F gene) of HMPV circulating in the cohort between 2012 and 2014 (Fig. 4A). The size of these clusters was generally small (dyads) and involved various HMPV sub-lineages, suggesting the presence of multiple sub-epidemics in the population with no apparent evidence of a major outbreak. Nonetheless, the increased frequency of transmission clusters correlated with the incidence of HMPV detection (Fig. 3B), indicating the potential roles of transmission clusters in driving the spread of respiratory infections. We were also able to estimate the directionality of viral transmission between individuals within the cluster, which allows the identification of the putative donor/recipient that may be important in facilitating efforts to minimize forward transmission18. Nevertheless, it is important to note that the transmission clusters inferred herein reflected the genetic relatedness of the viral sequences and their direction of transmission, without implying an actual (direct) viral transmission between clustered individuals18,19,24.

In order to understand the potential transmission and spread of infectious diseases such as the pandemic influenza, there has been a considerable amount of research on the role of social contact network in spreading a disease within the community. These studies used conceptualized frameworks38 or computational models39 to investigate the social contact network among schoolchildren and teenagers, and simulate how network interventions can significantly contain the spread of influenza within a community. However, most studies relied on the use of survey and contact diaries method which are laborious and often unreliable due to self-report inaccuracies, such as incomplete or illegible survey forms38 and failure to recall their network members precisely40. Therefore, our method presents a simple and unbiased approach to construct the transmission network based on the clustering of genetically-related viral strains sequenced from the infected individuals.

Although the potential use of transmission cluster in understanding HMPV spread has been demonstrated here, limitation does exist in the analysis, such as the lack of vital epidemiological information and the observed discordant clustering generated by different genetic regions. Firstly, to improve the cluster resolution and minimize potential discrepancies in the analysis, estimated clusters should be interpreted in parallel with information of contact history among members of a cluster, if available41. Likewise, the suitability of a genetic region can be determined through known transmission pairs sampled from well-documented outbreaks by assessing the reproducibility of the cluster features using multiple partial and even the complete genomes. In addition, although cluster overestimation may be unlikely in our analysis where the upper distance cutoffs were set below the lower 0.025 percentile of inter-person genetic distances24,42, the availability of the intra-person genetic distances will nonetheless provide a better clue on the lower distance cutoffs. Due to the interim and self-limiting nature of the infection, it is indeed a challenge to collect serial samples throughout acute illness, which will not immediately benefit the patients. Lastly, as in many other molecular epidemiological surveillance studies, only a subset of the population was recruited and analysed. Therefore, the size, frequency and structure of the transmission clusters observed could have been more accurate by increasing the sample size involving more recruitment sites (but not necessarily longer study duration).

In summary, the present study characterised the recent prevalence, seasonality and genetic diversity of HMPV in a large outpatient population presented with acute respiratory tract infections in Kuala Lumpur, Malaysia. The incorporation of transmission network analysis further demonstrated a deeper understanding of HMPV transmission dynamics in the population. Due to the epidemiological impact of HMPV in causing acute respiratory infections, continuous molecular surveillance is warranted to inform the development of therapeutic and preventive approaches, and to facilitate the monitoring of disease outbreaks in the population.

Materials and Methods

Ethics statement

The study was approved by the University Malaya Medical Centre (UMMC) Medical Ethics Committee. Standard, multilingual consent forms allowed by the Medical Ethics Committee were used and written consent was obtained from all study participants. All experiments were performed in accordance with approved guidelines and regulations.

Study population and sample collection

Nasopharyngeal swabs were collected from adults and children (aged 18 years and below) attending the primary care clinic in UMMC, Kuala Lumpur, Malaysia for a period of 28 months between February 2012 and May 2014. Eligible individuals were those who experienced symptoms of acute upper RTIs (URTI) for not more than two weeks at the time of study recruitment, defined as the presence of either sneezing, nasal discharge/congestion, headache, sore throat, hoarseness of voice, muscle ache and cough, as implemented in other studies on both naturally acquired and experimental colds43,44,45,46. The estimated number of days since the development of first disease symptom (estimated days after disease onset) was recorded. Nasopharyngeal swabs were stored in universal transport medium (Copan Diagnostics, California, USA) and transported to the laboratory for immediate processing.

Detection of human metapneumovirus

Total viral nucleic acid was extracted from 200 μL of specimen using the NucliSENS easyMAG automated platform (bioMerieux, Durham, North Carolina, USA) according to the manufacturer’s recommendation. One-step multiplex PCR was performed using the xTAG Respiratory Viral Panel (RVP) FAST Assay (Luminex Molecular Diagnostics Inc., Toronto, Canada) according to the manufacturer’s recommendation47. An internal positive control (Escherichia coli phage MS2) and a positive run control (bacteriophage lambda DNA) were included to monitor the assay performance. The resulting median fluorescence intensities were analysed using the Luminex 200 IS platform (Luminex Molecular Diagnostics Inc.).

Amplification and sequencing of the F and G genes

Viral RNA from HMPV-positive samples was reverse-transcribed to cDNA using SuperScript III RNase H Reverse Transcriptase (Invitrogen, Carlsbad, California, USA) and random hexamers (Applied Biosystems, Foster City, California, USA). The partial F open reading frame (ORF) (550 bp) and the complete G ORF (580–889 bp) of HMPV were amplified using primers as described previously10 using BIO-X-ACT Short DNA Polymerase enzyme (Bioline Reagents Ltd, UK) under the following thermocycling conditions: initial denaturation at 95 °C for 5 minutes, followed by 35 cycles of denaturation at 94 °C for 30 seconds, annealing at 55 °C for 1 minute and elongation at 72 °C for 1 minute, and a final elongation step at 72 °C for 10 minutes. Overall, two separate sets of nested primers were used to amplify the G genes. For specimens that failed to be amplified, we used the following sets of newly designed nested primers: outer primers set F1_6206, 5′-AAAACAARAAWATGGGACAAG-3′ and R1_7176, 5′-TCAGGRAGATARACATTRACAG-3′; and inner primers set F2_6258, 5′-RGCRAYWGACATGYTCAAAG-3′ and R3_7139, 5′-GATCCATTGYYATTTRTCYC-3′. Population sequencing was performed in both directions using an ABI PRISM 3730XL DNA Analyzer with BigDye terminators (Applied Biosystems). The newly-generated F and G gene sequences in this study were submitted in GenBank (accession numbers: KU254673 to KU254757 and KU320892 to KU320973).

Phylogenetic and sequence analysis

Global (n = 214) and regional (n = 170) published nucleotide sequences of HMPV F and G genes were retrieved from the GenBank database and aligned with the newly-generated sequences using the PRANK algorithm available on the GUIDANCE server48,49. In addition, 21 HMPV F and G sequences amplified among paediatrics diagnosed with acute lower RTIs by our laboratory were also included in the phylogenetic analysis (GenBank accession numbers: KJ196300 to KJ1963023 and KT852792 to KT852803). These samples were collected between April 2010 and December 2012 and were laboratory-confirmed as HMPV-positive by direct fluorescent-antibody staining and/or virus culture, as described previously7. Reference strains of HMPV genotype A and B sub-lineages comprising AF371337 HMPV NL/1/00/A1, AY297749 HMPV CA/83/97/A2a, AY530095 HMPV JP/240/03/A2b, GQ153651 HMPV CN/gz01/08/A2, AY525843 HMPV NL/1/99/B1 and GQ153651 HMPV CA/75/98/B2 were included1,12. Phylogenetic trees were constructed by the neighbour joining method based on the Kimura two-parameter model with a transition-transversion ratio of 2.0 implemented in MEGA 5.0550. The reliability and robustness of the branching orders were analysed by bootstrap analysis of 1,000 replicates. The mean genetic distances of nucleotide and amino acid sequences within and between genotypes/sub-lineage were estimated using the Kimura two-parameter model in MEGA.

HMPV transmission network

The HMPV transmission network was inferred from the newly-sequenced F and G genes based on the Tamura-Nei 93 (TN93) pairwise distance estimates51 performed using a custom script in Python (release 3.2.6) with 1,000 bootstrap replicates. A transmission cluster is characterised by the presence of at least two individuals (represented by nodes) whose viral sequences are genetically linked (represented by edges) at a given genetic distance threshold or cutoff18,19. The genetic distance cutoff values can be determined between the highest and lowest values of intra- and inter-person distances (known as the patristic distances), respectively24,42. However, since HMPV is associated with acute infection, measuring intra-person viral genetic distance is often challenging and impractical due to rapid viral clearance within a host. We therefore estimated the most probable cutoff values by determining the lower 0.025 percentile of the inter-person genetic distances calculated from the global F (n = 66) and G (n = 45) reference sequences representing all known genotypes and sub-lineages. Sequences from different individuals with genetic distance falling below these cutoffs were classified as transmission cluster. Clusters were described as dyads if they contain two nodes, and network if >2 nodes19. The estimated date of infection (EDI) for each individual was predated from the number of days after disease symptoms onset as reported by the patients and the incubation period of 4–6 days for HMPV28. Difference between EDI for each individual was denoted as ΔEDI. In addition to genetic distance cutoff, adjacent nodes with a ΔEDI of less than 30 days were considered in cluster construction (viral shedding beyond 30 days following primary infection is probably uncommon, hence viral transmission may be very limited or absent). Such criterion was used for an acute infection in order to improve the analytical power of cluster determination by effectively eliminating genetically similar but epidemiologically unrelated viruses that may complicate transmission cluster interpretation. Probable direction of virus transmission within a cluster was also estimated by placing a directed edge from the putative “donor” node to the “recipient” node(s), where the EDIdonor is older than the EDIrecipient18.

Statistical analysis

We analysed the effects of various climatic factors, namely the daily ground temperature, relative humidity, number of rainy days, total amount of rainfall and PM10, on the prevalence of HMPV in Kuala Lumpur during the study period. All important meteorological parameters provided by the Malaysian Meteorological Department were obtained from a weather station (coordinates: 3°06′N (latitude) and 101°39′N (longitude)) situated approximately 2 km away from UMMC52. Data was analysed using Pearson correlation coefficient and performed on the SPSS statistical package (version 21.0, IBM).

Additional Information

How to cite this article: Chow, W. Z. et al. Genetic diversity, seasonality and transmission network of human metapneumovirus: identification of a unique sub-lineage of the fusion and attachment genes. Sci. Rep. 6, 27730; doi: 10.1038/srep27730 (2016).

Supplementary Material

Supplementary Information
srep27730-s1.pdf (115.9KB, pdf)

Acknowledgments

We would like to thank Nyoke Pin Wong, Jack Bee Chook, See Wie Teoh, Anna Marie Nathan, Jessie Anne de Bruyne, and Jamal I-Ching Sam for assistance and support. This work was supported by grants from the Ministry of Education, Malaysia: High Impact Research UM.C/625/1/HIR/MOE/CHAN/02/02 to KKT.

Footnotes

Author Contributions Conceived and designed the experiments: W.Z.C. and K.K.T. Performed the experiments: W.Z.C., X.Y.O., L.J.N., S.S.N., K.T.N. and K.K.T. Analyzed the data: W.Z.C., Y.F.C., X.Y.O., L.J.N., K.T.N., K.G.C., N.S.H., Y.K.P., A.K. and K.K.T. Contributed reagents/material: W.Z.C., Y.F.C., X.Y.O., L.J.N., S.S.N., K.T.N., K.G.C., N.S.H., Y.K.P., A.K., and K.K.T. Wrote the paper: W.Z.C. and K.K.T. All authors reviewed the manuscript.

References

  1. van den Hoogen B. G. et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 7, 719–724 (2001). [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. van den Hoogen B. G. et al. Prevalence and clinical symptoms of human metapneumovirus infection in hospitalized patients. J Infect Dis 188, 1571–1577 (2003). [DOI] [PubMed] [Google Scholar]
  3. Boivin G. et al. Human metapneumovirus infections in hospitalized children. Emerg Infect Dis 9, 634–640 (2003). [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Loo L. H. et al. Human metapneumovirus in children, Singapore. Emerg Infect Dis 13, 1396–1398 (2007). [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Nair H. et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 375, 1545–1555 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Arnott A. et al. Genetic variability of human metapneumovirus amongst an all ages population in Cambodia between 2007 and 2009. Infect Genet Evol 15, 43–52 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Nor’e S. S. et al. Phylogenetic analysis of human metapneumovirus among children with acute respiratory infections in Kuala Lumpur, Malaysia. Trop Biomed 31, 562–566 (2014). [PubMed] [Google Scholar]
  8. Horthongkham N., Athipanyasilp N., Sirijatuphat R., Assanasen S. & Sutthent R. Prevalence and molecular characterization of human metapneumovirus in influenza a negative sample in Thailand. J Clin Lab Anal 28, 398–404 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Edwards K. M. et al. Burden of human metapneumovirus infection in young children. N Engl J Med 368, 633–643 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. van den Hoogen B. G. et al. Antigenic and genetic variability of human metapneumoviruses. Emerg Infect Dis 10, 658–666 (2004). [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Huck B. et al. Novel human metapneumovirus sublineage. Emerg Infect Dis 12, 147–150 (2006). [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Papenburg J. et al. Genetic diversity and molecular evolution of the major human metapneumovirus surface glycoproteins over a decade. J Clin Virol 58, 541–547 (2013). [DOI] [PubMed] [Google Scholar]
  13. Aberle J. H., Aberle S. W., Redlberger-Fritz M., Sandhofer M. J. & Popow-Kraupp T. Human metapneumovirus subgroup changes and seasonality during epidemics. Pediatr Infect Dis J 29, 1016–1018 (2010). [DOI] [PubMed] [Google Scholar]
  14. Rafiefard F., Yun Z. & Orvell C. Epidemiologic characteristics and seasonal distribution of human metapneumovirus infections in five epidemic seasons in Stockholm, Sweden, 2002–2006. J Med Virol 80, 1631–1638 (2008). [DOI] [PubMed] [Google Scholar]
  15. Mizuta K. et al. Seasonal patterns of respiratory syncytial virus, influenza A virus, human metapneumovirus, and parainfluenza virus type 3 infections on the basis of virus isolation data between 2004 and 2011 in Yamagata, Japan. Jpn J Infect Dis 66, 140–145 (2013). [DOI] [PubMed] [Google Scholar]
  16. Seo Y. B. et al. Etiology and clinical outcomes of acute respiratory virus infection in hospitalized adults. Infect Chemother 46, 67–76 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Wang X. et al. Targeting HIV Prevention Based on Molecular Epidemiology Among Deeply Sampled Subnetworks of Men Who Have Sex With Men. Clin Infect Dis 61, 1462–1468 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Little S. J. et al. Using HIV networks to inform real time prevention interventions. PLoS One 9, e98443 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Aldous J. L. et al. Characterizing HIV transmission networks across the United States. Clin Infect Dis 55, 1135–1143 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Bozick B. A. & Real L. A. The Role of Human Transportation Networks in Mediating the Genetic Structure of Seasonal Influenza in the United States. PLoS Pathog 11, e1004898 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Aris-Brosou S. Inferring influenza global transmission networks without complete phylogenetic information. Evol Appl 7, 403–412 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. McWilliam Leitch E. C. et al. Transmission networks and population turnover of echovirus 30. J Virol 83, 2109–2118 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Famulare M. & Hu H. Extracting transmission networks from phylogeographic data for epidemic and endemic diseases: Ebola virus in Sierra Leone, 2009 H1N1 pandemic influenza and polio in Nigeria. Int Health 7, 130–138 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Poon A. F. et al. The impact of clinical, demographic and risk factors on rates of HIV transmission: a population-based phylogenetic analysis in British Columbia, Canada. J Infect Dis 211, 926–935 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Samransamruajkit R., Thanasugarn W., Prapphal N., Theamboonlers A. & Poovorawan Y. Human metapneumovirus in infants and young children in Thailand with lower respiratory tract infections; molecular characteristics and clinical presentations. J Infect 52, 254–263 (2006). [DOI] [PubMed] [Google Scholar]
  26. Zeng S. Z. et al. Clinical features of human metapneumovirus genotypes in children with acute lower respiratory tract infection in Changsha, China. J Med Virol 87, 1839–1845 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Falsey A. R., Erdman D., Anderson L. J. & Walsh E. E. Human metapneumovirus infections in young and elderly adults. J Infect Dis 187, 785–790 (2003). [DOI] [PubMed] [Google Scholar]
  28. Peiris J. S. et al. Children with respiratory disease associated with metapneumovirus in Hong Kong. Emerg Infect Dis 9, 628–633 (2003). [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Reiche J. et al. Human metapneumovirus: insights from a ten-year molecular and epidemiological analysis in Germany. PLoS One 9, e88342 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Papenburg J. et al. Comparison of risk factors for human metapneumovirus and respiratory syncytial virus disease severity in young children. J Infect Dis 206, 178–189 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Kong W. et al. Circulation of human metapneumovirus among children with influenza-like illness in Wuhan, China. J Med Virol 88, 774–781 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Velez Rueda A. J., Mistchenko A. S. & Viegas M. Phylogenetic and phylodynamic analyses of human metapneumovirus in Buenos Aires (Argentina) for a three-year period (2009–2011). PLoS One 8, e63070 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Mackay I. M. et al. Genetic diversity of human metapneumovirus over 4 consecutive years in Australia. J Infect Dis 193, 1630–1633 (2006). [DOI] [PubMed] [Google Scholar]
  34. Lamson D. M., Griesemer S., Fuschino M. & St George K. Phylogenetic analysis of human metapneumovirus from New York State patients during February through April 2010. J Clin Virol 53, 256–258 (2012). [DOI] [PubMed] [Google Scholar]
  35. Yang C. F. et al. Genetic diversity and evolution of human metapneumovirus fusion protein over twenty years. Virol J 6, 138 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Neemuchwala A., Duvvuri V. R., Marchand-Austin A., Li A. & Gubbay J. B. Human metapneumovirus prevalence and molecular epidemiology in respiratory outbreaks in Ontario, Canada. J Med Virol 87, 269–274 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Schuster J. E. et al. Human Metapneumovirus Infection in Jordanian Children: Epidemiology and Risk Factors for Severe Disease. Pediatr Infect Dis J 34, 1335–1341 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Glass L. M. & Glass R. J. Social contact networks for the spread of pandemic influenza in children and teenagers. BMC Public Health 8, 61 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Salathe M. et al. A high-resolution human contact network for infectious disease transmission. Proc Natl Acad Sci USA 107, 22020–22025 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Bell D. C., Belli-McQueen B. & Haider A. Partner Naming and Forgetting: Recall of Network Members. Soc Networks 29, 279–299 (2007). [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Craft M. E. Infectious disease transmission and contact networks in wildlife and livestock. Philos Trans R Soc Lond B Biol Sci 370, 20140107–20140119 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Olmstead A. D. et al. A molecular phylogenetics-based approach for identifying recent hepatitis C virus transmission events. Infect Genet Evol 33, 101–109 (2015). [DOI] [PubMed] [Google Scholar]
  43. Jackson G. G., Dowling H. F., Spiesman I. G. & Boand A. V. Transmission of the common cold to volunteers under controlled conditions. I. The common cold as a clinical entity. AMA Arch Intern Med 101, 267–278 (1958). [DOI] [PubMed] [Google Scholar]
  44. Yale S. H. & Liu K. Echinacea purpurea therapy for the treatment of the common cold: a randomized, double-blind, placebo-controlled clinical trial. Arch Intern Med 164, 1237–1241 (2004). [DOI] [PubMed] [Google Scholar]
  45. Zitter J. N., Mazonson P. D., Miller D. P., Hulley S. B. & Balmes J. R. Aircraft cabin air recirculation and symptoms of the common cold. JAMA 288, 483–486 (2002). [DOI] [PubMed] [Google Scholar]
  46. Turner R. B. et al. Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trial. JAMA 281, 1797–1804 (1999). [DOI] [PubMed] [Google Scholar]
  47. Pabbaraju K., Wong S., Tokaryk K. L., Fonseca K. & Drews S. J. Comparison of the Luminex xTAG respiratory viral panel with xTAG respiratory viral panel fast for diagnosis of respiratory virus infections. J Clin Microbiol 49, 1738–1744 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Penn O. et al. GUIDANCE: a web server for assessing alignment confidence scores. Nucleic Acids Res 38, W23–28 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Loytynoja A. & Goldman N. Phylogeny-aware gap placement prevents errors in sequence alignment and evolutionary analysis. Science 320, 1632–1635 (2008). [DOI] [PubMed] [Google Scholar]
  50. Tamura K. et al. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28, 2731–2739 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Tamura K. & Nei M. Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees. Mol Biol Evol 10, 512–526 (1993). [DOI] [PubMed] [Google Scholar]
  52. Oong X. Y. et al. Epidemiological and Evolutionary Dynamics of Influenza B Viruses in Malaysia, 2012–2014. PLoS One 10, e0136254 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Buchholz U., Collins P., Fouchier R., van den Hoogen B. & Williams J. V. Naming convention for human metapneumovirus strains. International Committee on Taxonomy of Viruses (ICTV) (2012). [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Information
srep27730-s1.pdf (115.9KB, pdf)

Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES